NVDA is the week's centrepiece. Morgan Stanley raised its price target to $285, maintaining Overweight. The chip giant reports Q1 FY2027 results on Wednesday. Options traders have loaded up on near-dated calls. Bullish flow across MU and AMD adds to the semiconductor momentum. MRVL is also moving Monday on fresh chip sector tailwinds.
LRCX received an upgrade today, adding to the positive tone in semis. Meanwhile, REGN was downgraded to Market Perform at Leerink Partners, with the target cut to $641. Biotech sentiment stays mixed.
On the short side, Wolfspeed remains the most extreme name. SI sits at 107% of free float. Availability has collapsed to near zero. carries 39% SI with cost to borrow above 25%. hit 96% utilization today — near its 52-week peak.
Insider signals are constructive. Colliers CEO Jay Hennick spent $29M buying his own stock across three days. Waste Connections founder Ronald Mittelstaedt added $7.6M personally. New KHC CEO Steve Cahillane put in $5M on day one. That level of buying from sitting executives is notable.
XPeng began mass production of its robotaxi at its Guangzhou plant today. That puts China's EV makers back in the spotlight. The development signals real-world autonomous vehicle timelines are compressing faster than many expected.
Earnings risk looms large. TGT, LOW, and INTU all report Wednesday alongside NVDA. Consumer and housing sentiment will be tested. The week's results could reset market expectations heading into June.
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
